Inflammometry to assess airway diseases. (Q51868746)

14 April 2018

title

Inflammometry to assess airway diseases. (English)

1 reference

14 April 2018

author

Ian D. Pavord

1

1 reference

14 April 2018

Dominick Shaw

object named as

Dominick E Shaw

2

0 references

Peter G Gibson

object named as

Peter G Gibson

3

0 references

Robin Taylor

4

object named as

D Robin Taylor

1 reference

14 April 2018

language of work or name

English

0 references

publication date

1 September 2008

1 reference

14 April 2018

published in

The Lancet

1 reference

14 April 2018

volume

372

1 reference

14 April 2018

issue

9643

1 reference

14 April 2018

page(s)

1017-1019

1 reference

14 April 2018

A comparison of the validity of different diagnostic tests in adults with asthma.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Multiple inflammatory hits and the pathogenesis of severe airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Treatment of chronic asthma with prednisolone; significance of eosinophils in the sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Non-eosinophilic cor ticosteroid unresponsive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Exhaled nitric oxide: a predictor of steroid response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Use of exhaled nitric oxide measurements to guide treatment in chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961421-X

7 January 2021

10.1016/S0140-6736(08)61421-X

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018